Moisand Fitzgerald Tamayo’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Moisand Fitzgerald Tamayo’s Portfolio NARI Stock Details NARI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-9	Closed	-$1K	–	909
2022 Q2	$1K	Sell	9 -8	-47%	-$575	﹤0.01%	582
2022 Q1	$2K	Buy	+17	New	+$1.39K	﹤0.01%	426

Other funds holding NARI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Moisand Fitzgerald Tamayo's NARI Position: Q3 2022 in Review

Moisand Fitzgerald Tamayo sold out of Inari Medical, Inc. Common Stock (NARI) in Q3 2022, closing a stake of 9 shares — an estimated $1K sold.

Moisand Fitzgerald Tamayo first reported a position in NARI in Q1 2022 and held it in 2 quarters. The position peaked at $2K in Q1 2022. 240 funds tracked by Wall St. Rank hold NARI as of Q3 2022.

Moisand Fitzgerald Tamayo reported no remaining Inari Medical, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Moisand Fitzgerald Tamayo sold 9 Inari Medical, Inc. Common Stock shares in Q3 2022, an estimated $1K.
Moisand Fitzgerald Tamayo first reported a position in Inari Medical, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
Moisand Fitzgerald Tamayo's Inari Medical, Inc. Common Stock position peaked at $2K in Q1 2022.
240 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q3 2022.

Based on Moisand Fitzgerald Tamayo's 13F filing for Q3 2022, filed 26 Oct 2022.